Skip to search.
 BSE Up 1.74% NSE Up 1.79%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
6.52 Down 0.35(5.09%) 8 Dec 2:30am
|Pre-Market : 6.52 0.00 (0.00%) 3:15am - Nasdaq Real Time Price
Prev Close:6.87
Open:N/A
Bid:6.10 x 2000
Ask:7.65 x 100
1y Target Est:21.00
Beta:1.96609
Earnings Date:22 Feb - 27 Feb (Est.)
Day's Range:N/A - N/A
52wk Range:4.45 - 10.49
Volume:0
Avg Vol (3m):1,934,760
Market Cap:850.63M
P/E (ttm):N/A
EPS (ttm):-1.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 5.09%850.63M
IMGNDown 6.57%161.51M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):124.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.33
Quarterly EPS Est (Dec-16) :-0.11
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback